pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 29·3 min read
save

5 takeaways from STAT’s investigation into microhospital operator Nutex Health

Read the takeaways from STAT's investigation into Nutex, which used the No Surprises Act to fuel a stunning financial turnaround.

Jun 29, 2026·read at STAT ↗RegulatoryNeutral

A STAT Investigation 5 takeaways from STAT’s investigation into microhospital operator Nutex Health Nutex profited from loopholes in laws meant to protect patients, STAT found Manage alerts for this article Email this article Share this article By Tara BannowJune 29, 2026 Hospitals and Insurance Reporter Tara Bannow[email protected]Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about health insurance and ideas for improving our broken health system.

You can reach Tara on Signal at tarabannow.70. Nutex Health is a Houston-based microhospital operator whose finances have been transformed by the No Surprises Act’s arbitration process. STAT took a close look at the company and discovered it’s far from a typical hospital operator.

Uninsured patients report being turned away if they don’t pay up front Several patients told STAT they visited Nutex’s emergency rooms and were refused care unless they paid up front. One of those patients went to another hospital and discovered he’d suffered a heart attack. Nutex claims it screens all patients for medical emergencies and won’t turn anyone away who’s experiencing one.

Advertisement Nutex’s profit soared after it started using No Surprises Act arbitration The company teetered on the edge of bankruptcy after the No Surprises Act banned balance billing, but less than a year after Nutex began filing arbitration disputes, its revenue tripled and profit grew nearly twelvefold. Nutex relies on HaloMD to takes its disputes through arbitration HaloMD is a Texas-based middleman whose tactics are the subject of multiple lawsuits. A STAT investigation found that the couple behind the company built their wealth on profit-sharing arrangements with surgeons that sources described as unethical and potentially illegal.

Nutex investors are suing, government agencies investigating In multiple lawsuits that are now combined, Nutex investors accuse the company of hiding its partnership with HaloMD and say the dubious arrangement exposes the company to further legal risks. Nutex’s practices are being investigated by regulators in Idaho and New Mexico. Advertisement Patients say they received exorbitant bills STAT interviewed patients who had to pay thousands of dollars for brief visits to Nutex hospitals, and their health insurers were charged even more.

Previously, during the Covid-19 pandemic, patients said Nutex billed their insurers between $2,000 and $5,000 for Covid-19 tests. One family’s insurance paid Nutex $21,000 for five tests. Read more: The ERs that can turn patients away — and are reaping millions Congress, health care costs, Health insurance, hospitals, Policy Submit a correction requestReprints Tara Bannow Hospitals and Insurance Reporter Tara covers the business of health care.

Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about health insurance and ideas for improving our broken health system. You can reach Tara on Signal at tarabannow.70.

Newsletter Unpacking the business — and secretive inner workings — of the U.S. health care industry Recommended The Readout June 30, 2026 STAT Plus: Investors double down on Bain-backed startup Politics June 30, 2026 STAT Plus: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk Advertisement The Readout June 29, 2026 STAT Plus: Talawar bets bispecific approach can shake up eczema market A STAT Investigation June 29, 2026 STAT Plus: The ERs that can turn patients away — and are reaping millions The Readout June 26, 2026 STAT Plus: Embryo editing advances reignite ethical debates Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
579 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7ELI LILLY COEli Lilly and CoLILLYNOVONovo Nordisk Inc
drugs
Obesity
topics
Atopic DermatitisBispecific AntibodyCardiologyObesity

related stories

  • Jul 16Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunoBioSpace
  • Jul 1STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenesSTAT
  • Jun 30STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo NordiskSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 6d agoLilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist MounjaroBioSpace